Abstract
Epinephrine (Epi), which initiates short-term responses to cope with stress, is, in part, stress-regulated via genetic control of its biosynthetic enzyme, phenylethanolamine N-methyltransferase (PNMT). In rats, immobilization (IMMO) stress activates the PNMT gene in the adrenal medulla via Egr-1 and Sp1 induction. Yet, elevated Epi induced by acute and chronic stress is associated with stress induced, chronic illnesses of cardiovascular, immune, cancerous, and behavioral etiologies. Major sources of Epi include the adrenal medulla and brainstem. Although catecholamines do not cross the blood–brain barrier, circulating Epi from the adrenal medulla may communicate with the central nervous system and stress circuitry by activating vagal nerve β-adrenergic receptors to release norepinephrine, which could then stimulate release of the same from the nucleus tractus solitarius and locus coeruleus. In turn, the basal lateral amygdala (BLA) may activate to stimulate afferents to the hypothalamus, neocortex, hippocampus, caudate nucleus, and other brain regions sequentially. Recently, we have shown that repeated IMMO or force swim stress may evoke stress resiliency, as suggested by changes in expression and extinction of fear memory in the fear-potentiated startle paradigm. However, concomitant adrenergic changes seem stressor dependent. Present studies aim to identify stressful conditions that elicit stress resiliency versus stress sensitivity, with the goal of developing a model to investigate the potential role of Epi in stress-associated illness. If chronic Epi over expression does elicit illness, possibilities for alternative therapeutics exist through regulating stress-induced Epi expression, adrenergic receptor function and/or corticosteroid effects on Epi, adrenergic receptors and the stress axis.
Similar content being viewed by others
References
Abraham J, Mudd JO, Kapur N, Klein K, Champion HC, Wittstein IS (2009) Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 53:1320–1325
Ameredes BT (2011) Beta-2-receptor regulation of immunomodulatory proteins in airway smooth muscle. Front Biosci (Schol Ed) 3:643–654
Cahill L, Alkire MT (2003) Epinephrine enhancement of human memory consolidation: interaction with arousal at encoding. Neurobiol Learn Mem 79:194–198
Cannon WG, De La Paz D (1911) Emotional stimulation of adrenal secretion. Am J Physiol 28:64–70
Carlezon WA Jr, Rohan ML, Mague SD, Meloni EG, Cayetano K, Tomasiewicz HC, Rouse ED, Cohen BM, Renshaw PF (2005) Antidepressant-like effects of cranial stimulation within a low energy magnetic field in rats. Biol Psychiatry 57:571–576
Davis M, Astrachan DI (1978) Conditioned fear and startle magnitude: effects of different footshock or backshock intensities used in training. J Exp Psychol Anim Behav Process 4:95–103
Debiec J, Bush DEA, LeDoux JE (2011) Noradrenergic enhancement of reconsolidation in the amygdala impairs extinction of conditioned fear in rats—a possible mechanism for the persistence of traumatic memories in PTSD. Depress Anxiety 28:186–193
Dikanović M, Demarin V, Kadojić D, Kadojić M, Trkanjec Z, Titlić M, Bitunjac M, Soldo-Butković S (2011) Effect of elevated catecholamine levels on cerebral hemodynamics in patients with chronic post-traumatic stress disorder. Coll Antropol 35:471–475
Dimsdale JE (2008) Psychological stress and cardiovascular disease. J Am Coll Cardiol 51:1237–1246
Donovan E (2010) Propranolol use in the prevention and treatment of posttraumatic stress disorder in military veterans: forgetting therapy revisited. Prespect Biol Med 53:61–74
Ebert SN, Wong DL (1995) Differential activation of the rat phenylethanolamine N-methyltransferase gene by Sp1 and Egr-1. J Biol Chem 270:17299–17305
Ebert SN, Balt SL, Hunter JPB, Gashler A, Sukhatme V, Wong DL (1994) Egr-1 activation of rat adrenal phenylethanolamine N-methyltransferase gene. J Biol Chem 269:20885–20898
Ebert SN, Ficklin MB, Her S, Siddall BJ, Bell RA, Morita K, Ganguly K, Wong DL (1998) Glucocorticoid-dependent action of neural crest factor AP-2: stimulation of phenylethanolamine N-methyltransferase gene expression. J Neurochem 70:2286–2295
Esler M (2010) The 2009 Carl Ludwig Lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 108:227–237
Fineschi V, Michalodimitrakis M, D’Errico S, Neri M, Pomara C, Piezzo I, Turillazzi E (2010) Insight into stress-induced cardiomyopathy and sudden cardiac death due to stress. A forensic cardio-pathologist point of view. Forensic Sci Int 194:1–8
Fragala MS, Kraemer WJ, Mastro AM, Denegar CR, Volek JS, Hakkinen K, Anderson JM, Lee EC, Maresh CM (2011) Leukocyte b2-adrenergic receptor expression in response to resistance exercise. Med Sci Sports Exerc 43:1422–1432
Gaykema RP, Goehler LE (2011) Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behaviors: brain substrates for fatigue. Brain Behav Immun 25:443–460
Greene LA, Tischler AS (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424–2428
Gwinn GT (1951) Resistance to extinction of learned fear-drives. J Exp Psychol 42:6–12
Heffner KL (2011) Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease. Immunol Allergy Clin North Am 31:95–108
Her S, Bell RA, Bloom AK, Siddall BJ, Wong DL (1999) Phenylethanolamine N-methyltransferase gene expression: Sp1 and MAZ potential for tissue specific expression. J Biol Chem 274:8698–8707
Her S, Claycomb R, Tai TC, Wong DL (2003) Regulation of the rat phenylethanolamine N-methyltransferase gene by transcription factors Sp1 and MAZ. Mol Pharmacol 64:1180–1188
Herault J, Perrot A, Barthelemy C, Buchler M, Cherpi C, Leboyer M, Sauvage D, Lelord G, Mallet J, Muh J (1993) Possible association of c-Harvey-Ras-1 (HRAS-1) marker with autism. Psychiatry Res 46:261–267
Higgins JP, Tuttle T, Higgins JA (2010) Altitude and the heart: is going high safe for your cardiac patient. Am Heart J 159:25–32
Hoffman BB (2001) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s the pharmacological basis of therapeutics, vol 10. McGraw Hill, New York, pp 215–268
Hokfelt T, Fuxe K, Goldstein M, Johansson O (1974) Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain. Brain Res 66:235–251
Hokfelt T, Johansson O, Goldstein M (1984) Central catecholamine neurons as revealed by immunochemistry with special reference to the adrenaline neurons. In: Bjorklund A, Hokfelt T (eds) Handbook of neuroanatomy, vol 2. Elsevier, Amsterdam, pp 157–276
Hopfl G, Ogunshola O, Gassmann M (2004) HIFs and tumors—causes and consequences. Am J Physiol Regul Integr Comp Physiol 286:R608–R623
Inbar S, Neeman E, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S (2011) Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS One 6:1–11
Izquierdo A, Wellman CL, Holmes A (2006) Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J Neurosci 26:5733–5738
Ji Y, Snyder EM, Fridley BL, Salavaggione OE, Moon I et al (2008) Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release. Physiol Genomics 33:323–332
Khouri S, Imran N (2009) Stress cardiomyopathy (Takotsubo cardiomyopathy). Clin Med Cardiol 3:93–99
Kostrzewa RM (2007) The blood–brain barrier for catecholamines—revisited. Neurotoxic Res 11:261–272
Kvetnansky R, Nankova B, Rusnak M, Micutkova L, Kubovcakova L, Dronjak SK, Krizanova O, Sabban EL (2002) Differential gene expression of tyrosine hydroxylase in rats exposed long-term to various stressors. In: Nagatsu T, Nabeshima T, McCarty R, Goldstein DS (eds) Catecholamine research: from molecular insights to clinical medicine vol. Plenum, New York, pp 317–320
Kvetnansky R, Sabban EL, Palkovits M (2009) Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol Rev 89:535–606
Laukova M, Vargovic P, Krizanova O, Kvetnansky R (2010) Repeated stress down-regulates β2- and α2C-adrenergic receptors and up-regulates gene expression of IL-6 in the rat spleen. Cell Mol Neurobiol 30:1077–1087
Launay JM, Bursztein C, Ferrari P (1987) Catecholamine metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord 17:333–347
Mausbach BT, Roepke SK, Ziegler MG, Milic M, von Kanel R, Dimsdale JE, Mills PJ, Patterson TL, Allison MA, Ancoli-Israel S, Grant I (2010) Association between chronic caregiving stress and impaired endothelial function in the elderly. J Am Coll Cardiol 55:2599–2606
McEwen BS (2007) Physiology and neurobiology of stress. Physiol Rev 87:873–904
McEwen BS, Gianaros PT (2010) Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease. Ann NY Acad Sci 1186:190–222
McGaugh JL (2004) The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 27:1–28
Meloni EG, Gerety LP, Knoll AT, Cohen BM, Carlezon WA Jr (2006) Behavioral and anatomical interactions between dopamine and corticotropin-releasing factor in the rat. J Neurosci 26:3855–3863
Mravec B (2011) Role of catecholamine-induced activation of vagal afferent pathways in regulation of sympathoadrenal system activity: negative feedback loop of stress response. Endocr Regul 45:37–41
Myers KM, Davis M (2004) AX+, BX- discrimination learning in the fear-potentiated startle paradigm: possible relevance to inhibitor fear learning in extinction. Learn Mem 11:464–475
Myers KM, Davis M (2007) Mechanisms of fear extinction. Mol Psychiatry 12:120–150
Peng Y-J, Nanduri J, Khan SA, Yuan G, Wang N, Kinsman B, Vaddi DR, Kumar GK, Garcia JA, Semenza GL, Prabhakar NR (2011) Hypoxia-inducible factor 2a (HIF-2a) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci USA 108:3065–3070
Roozendaal B, McEwen BS, Chattarji S (2009) Stress, memory and the amygdala. Nat Rev Neurosci 10:423–433
Ross ME, Evinger MJ, Hyman SE, Carroll JM, Mucke L, Comb M, Reis DJ, Joh TH, Goodman HM (1990) Identification of a functional glucocorticoid response element in the phenylethanolamine N-methyltransferase promoter using fusion genes introduced into chromaffin cells in primary culture. J Neurosci 10:520–530
Santra M, Santara S, Zhang J, Chopp M (2008) Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1α, and Stat3. J Neurochem 105:324–337
Schreurs J, Seelig T, Schulman H (1986) Beta 2-adrenergic receptors on peripheral nerves. J Neurochem 46:294–296
Sood AK, Armaiz-Pena GN, Halder J, Nick AM, Stone RL, Hu W, Carroll AR, Spannuth WA, Deavers MT, Allen JK, Han LY, Kamat AA, Shahzad MMK, McIntyre BW, Diaz-Montero CM, Jennings NB, Lin YG, Merritt WM, DeGeest K, Vivas-Mejia PE, Lopez-Berestein G, Schaller MD, Cole SW, Lutgendorf SK (2010) Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. J Clin Invest 120:1515–1523
Stone EA, Lin Y, Rosengarten H, Kramer HK, Quartermain D (2003) Emerging evidence for a central epinephrine-innervated α1-adrenergic system that regulates behavioral activation and is impaired in depression. Neuropsychopharmacology 28:1387–1399
Tai TC, Wong DL (2003) Protein kinase A and protein kinase C signaling pathway interaction in phenylethanolamine N-methytransferase gene regulation. J Neurochem 85:816–829
Tai TC, Claycomb R, Her S, Bloom AK, Wong DL (2002) Glucocorticoid responsiveness of the rat phenylethanolamine N-methyltransferase gene. Mol Pharmacol 61:1385–1392
Tai TC, Claycomb R, Siddall BJ, Bell RA, Kvetnansky R, Wong DL (2007) Stress-induced changes in epinephrine expression in the adrenal medulla in vivo. J Neurochem 101:1108–1118
Tai TC, Wong-Faull DC, Claycomb R, Wong DL (2009) Hypoxic stress-induced changes in adrenergic function: role of HIF1α. J Neurochem 109:513–524
Tai TC, Wong-Faull DC, Claycomb R, Wong DL (2010) Hypoxia and adrenergic function: molecular mechanisms related to Egr-1 and Sp1 activation. Brain Res 1353:14–27
Tillinger A, Bruderova V, Kubovcakova L, Zeman M, Kopacek J, Novakova M, Kvetnansky R, Krizanova O (2006) Gene expression of the phenylethanolamine N-methyltransferase is differently modulatedin cardiac atria and ventricles. Gen Physiol Biophys 25:355–364
Ulrich-Lai YM, Herman JP (2009) Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 10:397–409
Viskupic E, Kvetnansky R, Sabban EL, Fukuhara K, Weise VK, Kopin IJ, Schwartz JP (1994) Increase in rat adrenal phenylethanolamine N-methyltransferase mRNA level caused by immobilization stress depends on intact pituitary-adrenocortical axis. J Neurochem 63:808–814
Walker DL, Davis M (2002) Quantifying fear potentiated startle using absolute versus proportional increase scoring methods: implications for the neurocircuitry of fear and anxiety. Psychopharmacology 164:318–328
Wong DL, Tank AW (2007) Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress 10:121–130
Wong DL, Lesage A, Siddall B, Funder JW (1992) Glucocorticoid regulation of phenylethanolamine N-methyltransferase in vivo. FASEB J 6:3310–3315
Wong DL, Siddall BJ, Ebert SN, Bell RA, Her S (1998) Phenylethanolamine N-methyltransferase gene expression: synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor. Mol Brain Res 61:154–161
Wong DL, Her S, Tai TC, Bell RA, Rusnak M, Farkas R, Kvetnansky R, Shih J (2002) Stress-induced expression of phenylethanolamine N-methyltransferase: normal and knock out animals. In: McCarty R, Aguilera G, Sabban EL, Kvetnansky R (eds) Stress: neural, endocrine and molecular studies. Taylor and Francis, London, pp 129–135
Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Kvetnansky R (2004) Genetic mechanisms for adrenergic control during stress. In: Pacak K, Aguilera G, Sabban EL, Kvetnansky R (eds) Stress: current neuroendocrine and genetic approaches, vol 1018. Ann. N.Y. Acad. Sci, New York, pp 387–397
Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Kvetnansky R (2008) Adrenergic responses to stress: transcriptional and post-transcriptional changes. Ann NY Acad Sci 1148:249–256
Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Siddall BJ, Bell RA, Kvetnansky R (2010) Stress and adrenergic function: HIF1α, a potential regulatory switch. Cell Mol Neurobiol 30:1451–1457
Young EA, Breslau N (2004) Cortisol and catecholamines in posttraumatic stress disorder. Arch Gen Psychiatry 61:394–401
Zeb M, Sambu N, Scott P, Curzen N (2011) Takotsubo cardiomyopathy: a diagnostic challenge. Postgrad Med J 87:51–59
Zhang W, Shibamoto T, Kuda Y, Ohmukai C, Kurata Y (2011) Pulmonary vasoconstrictive and bronchoconstrictive responses to anaphylaxis are weakened via b2-adrenoceptor activation by endogenous epinephrine in anesthetized rats. Anesthesiology 114:614–623
Acknowledgments
This study was supported by The Spunk Fund, Inc., the Sobel-Keller Research Fund, McLean Hospital, and the Emerald Foundation, Inc. (DLW), NSERC and CIHR grants (TCT), MH063266 (WAC) and Slovak Grants, APVV-0088-10 and VEGA 2/0036-11 and 2/0188-09 (RK).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wong, D.L., Tai, T.C., Wong-Faull, D.C. et al. Epinephrine: A Short- and Long-Term Regulator of Stress and Development of Illness. Cell Mol Neurobiol 32, 737–748 (2012). https://doi.org/10.1007/s10571-011-9768-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-011-9768-0